glp 1 for substance use disorder IUPHAR review – Glucagon-like peptide-1 (GLP-1) and disorders: An emerging pharmacotherapeutic target GLP-1 drugs linked to lower

According to the World Health Organisation, obesity has nearly tripled since 1975, underscoring the urgent need for effective weight management strategies

GIP signaling may also modulate energy expenditure independently of appetite changes, meaning your body burns more calories even without eating less

Here are three key modifications I recommend: Regular physical activity : Incorporating exercise into my daily routine helps manage my weight and improve my insulin sensitivity

Narrative review of metabolic syndrome and its relationships with non-alcoholic fatty liver disease, gonadal dysfunction and obstructive sleep apnea

Fatty liver disease

From breakthrough mechanisms to real-world application, we give you the knowledge you need to stay sharp and stay ahead in GLP-1 science and patient care